Zobrazeno 1 - 10
of 26
pro vyhledávání: '"N. L. Lifshits"'
Autor:
I M, Kutyrina, S A, Martynov, M Iu, Shvetsov, N L, Lifshits, N G, Miroshnichenko, E P, Golitsina, V A, Varshavskiĭ
Publikováno v:
Terapevticheskii arkhiv. 76(9)
To study prevalence of arterial hypertension (AH) in patients with chronic glomerulonephritis (CGN), its relationship with activity of the renal process, renal function; to analyse policy and efficacy of antihypertensive therapy. MATERIAL AND METHODS
Autor:
I M, Kutyrina, N L, Lifshits, V A, Rogov, E S, Kamyshova, M Iu, Shvetsov, E B, Okonova, S O, Androsova, S A, Martynov, N G, Miroshnichenko, O I, Gerasimenko
Publikováno v:
Terapevticheskii arkhiv. 74(6)
To study effects of ACE inhibitors in patients with diffuse renal diseases at the stage of chronic renal failure (CRF).Acute changes in renal filtration and in renal hemodynamics in response to 100-200 mg captopril were studied in 7 patients with CRF
Publikováno v:
Terapevticheskii arkhiv. 74(6)
To assess prognostic implications of controlled and uncontrolled arterial hypertension (AH) in patients with terminal renal failure (TRF) on chronic hemodialysis (CHD).90 patients on CHD treated from 1981 to 2001 participated in the trial. All of the
Publikováno v:
Terapevticheskii arkhiv. 72(6)
Autor:
N L, Lifshits, I M, Kutyrina
Publikováno v:
Terapevticheskii arkhiv. 71(6)
To characterize status of renin-angiotensin-aldosterone system (RAAS) in patients with chronic and terminal renal failure (CRF, TRF) and its role in pathogenesis of arterial hypertension (AH).RAAS was studied in 90 patients with TRF on chronic hemodi
Autor:
N L, Lifshits, A Iu, Nikolaev
Publikováno v:
Terapevticheskii arkhiv. 71(1)
Autor:
A Iu, Nikolaev, N L, Lifshits
Publikováno v:
Urologiia i nefrologiia. (1)
Publikováno v:
Urologiia i nefrologiia. (3)
Twenty nine patients with chronic renal failure associated with severe essential hypertension, 10 of whom being on programmed hemodialysis, were treated with captopril, a converting enzyme inhibitor (n = 21) and sectral-400, a cardioselective beta-bl
Publikováno v:
Chemistry of Heterocyclic Compounds. 12:300-303
N1-(Nicotinoyl)-N2-4-(2,2,6,6-tetramethyl-4-hydroxypiperidine-1-oxyl)hydraxine was obtained by condensation of nicotinoyl hydrazide with 2,2,6,6-tetramethyl-4-oxopiperidine 1-oxyl. Acylation of 2,2,6,6-tetramethyl-4-hydroxypiperidine 1-oxyl with nico
Publikováno v:
Kardiologiia. 16(5)
Basing on the literature data and their own observations of patients with chronic hemodialysis the authors have analysed the pathogenesis, course, hemodynamic shifts and possibilities of purposeful treatment in terminal uremia. Besides two variants o